Skip to main content
Zai Lab Limited logo

Zai Lab Limited — Investor Relations & Filings

Ticker · 9688 ISIN · KYG9887T1168 LEI · 549300P2UYQ9U5LY1T58 HKEX Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2025-04-17 Governance Information
Country KY Cayman Islands
Listing HKEX 9688

About Zai Lab Limited

http://www.zailaboratory.com

Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing transformative therapies that address medical conditions with significant unmet needs. The company focuses its pipeline and development efforts across four core therapeutic areas: oncology, immunology, neuroscience, and infectious disease. Zai Lab employs a strategy of internal research and global partnerships to advance best-in-class and first-in-class medicines. A key commercial product is ZEJULA (niraparib), utilized as a maintenance treatment for ovarian cancer in markets including mainland China.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 87% confidence The document is a Hong Kong Exchange announcement listing the company’s current board members and their committee roles. It does not announce transactions, financial results, or a vote. Instead it provides details on board structure and committee memberships, matching the “Governance Information” category (CGR).
2025-04-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Share Issue/Capital Change Classification · 85% confidence The document is a monthly return (Form FF301) filed with the Hong Kong Stock Exchange under Chapter 19B, detailing the movements in authorised and issued share capital, exercises of options, RSU/PSU vesting/lapsing, and other share capital arrangements for the month ended 31 March 2025. It is not an annual or interim financial report, nor an earnings release or AGM material. It is a routine regulatory filing specifically announcing share issuance/capital changes. This corresponds to the “Share Issue/Capital Change” category (Code: SHA).
2025-04-07 English
GRANT OF SHARE OPTIONS, RESTRICTED SHARE UNITS AND PERFORMANCE SHARE UNITS
Share Issue/Capital Change Classification · 94% confidence The document is an official announcement under the Hong Kong Listing Rules (Rules 17.06A/17.06B/17.06C) detailing the grant of share options, restricted share units and performance share units under the Company’s 2024 Equity Incentive Plan. It is not a financial report, earnings release, or AGM material, nor is it a director insider trade notification. Instead, it relates to the issuance of equity under an incentive plan, which falls under share issue/capital change.
2025-04-03 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 85% confidence The document is a Next Day Disclosure Return under Hong Kong Listing Rules, detailing an issuer’s change in issued shares (new share issuance under equity incentive plans) and confirming compliance. This is an announcement of a share issue/capital change rather than a full annual or interim report, making it a Share Issue/Capital Change filing.
2025-04-03 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024' and contains detailed consolidated financial statements including balance sheets, statements of operations, cash flows, and notes. It includes an independent auditor's report with an opinion on the consolidated financial statements, audit basis, key audit matters, and responsibilities of directors and auditors. The document is comprehensive, covering the full fiscal year 2024, and includes detailed financial data and analysis. This matches the characteristics of an Annual Report (10-K equivalent) rather than a short announcement or a regulatory filing. The length of the document (15,000 characters) and the presence of full financial statements and audit report confirm it is the full annual report rather than just an announcement or certification. Therefore, the correct classification is Annual Report (10-K).
2025-03-27 English
NOTICE OF BOARD ACTION
Report Publication Announcement Classification · 83% confidence The document is a Notice of Board Action announcing the date when the board will consider, approve, and publish the Company’s annual results. It does not include the actual annual report but rather an announcement of timing for approval and publication of that report. This corresponds to 'Report Publication Announcement' (RPA).
2025-03-17 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.